Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals
XTalks
JANUARY 19, 2024
Over the last year, there have been new acquisitions, launches and deals for novel radiotherapeutics and newly created peptide-radioisotope drug conjugates. There have been more than $1.7 billion influx into radiopharmaceuticals which underscores the potential and robust growth in this therapeutic area.
66 
Let's personalize your content